rs6529

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001291415.2(KDM6A):​c.88G>A​(p.Ala30Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000333 in 1,193,516 control chromosomes in the GnomAD database, including 1 homozygotes. There are 102 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., 52 hem., cov: 23)
Exomes 𝑓: 0.00018 ( 1 hom. 50 hem. )

Consequence

KDM6A
NM_001291415.2 missense

Scores

2
9
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 5.44

Publications

5 publications found
Variant links:
Genes affected
KDM6A (HGNC:12637): (lysine demethylase 6A) This gene is located on the X chromosome and is the corresponding locus to a Y-linked gene which encodes a tetratricopeptide repeat (TPR) protein. The encoded protein of this gene contains a JmjC-domain and catalyzes the demethylation of tri/dimethylated histone H3. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Apr 2014]
KDM6A Gene-Disease associations (from GenCC):
  • Kabuki syndrome 2
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0070658326).
BP6
Variant X-44873639-G-A is Benign according to our data. Variant chrX-44873639-G-A is described in ClinVar as Benign. ClinVar VariationId is 134594.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00179 (202/112883) while in subpopulation AFR AF = 0.00622 (194/31187). AF 95% confidence interval is 0.0055. There are 0 homozygotes in GnomAd4. There are 52 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 202 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KDM6ANM_001291415.2 linkc.88G>A p.Ala30Thr missense_variant Exon 1 of 30 ENST00000611820.5 NP_001278344.1 A0A087X0R0B7ZKN5Q86TD1B7ZKN6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KDM6AENST00000611820.5 linkc.88G>A p.Ala30Thr missense_variant Exon 1 of 30 1 NM_001291415.2 ENSP00000483595.2 A0A087X0R0

Frequencies

GnomAD3 genomes
AF:
0.00180
AC:
203
AN:
112836
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000185
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00197
GnomAD2 exomes
AF:
0.000376
AC:
53
AN:
141040
AF XY:
0.000202
show subpopulations
Gnomad AFR exome
AF:
0.00555
Gnomad AMR exome
AF:
0.000169
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000174
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000180
AC:
195
AN:
1080633
Hom.:
1
Cov.:
32
AF XY:
0.000142
AC XY:
50
AN XY:
351807
show subpopulations
African (AFR)
AF:
0.00682
AC:
178
AN:
26104
American (AMR)
AF:
0.000185
AC:
6
AN:
32483
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19085
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29412
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52371
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38078
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3831
European-Non Finnish (NFE)
AF:
0.00000240
AC:
2
AN:
833902
Other (OTH)
AF:
0.000198
AC:
9
AN:
45367
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00179
AC:
202
AN:
112883
Hom.:
0
Cov.:
23
AF XY:
0.00148
AC XY:
52
AN XY:
35057
show subpopulations
African (AFR)
AF:
0.00622
AC:
194
AN:
31187
American (AMR)
AF:
0.000185
AC:
2
AN:
10817
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3527
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2809
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6234
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53215
Other (OTH)
AF:
0.00195
AC:
3
AN:
1539
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00141
Hom.:
10
Bravo
AF:
0.00248
ESP6500AA
AF:
0.00353
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000421
AC:
49

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 19, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

May 01, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KDM6A-related disorder Benign:1
Jun 14, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Intellectual disability Benign:1
Jan 01, 2019
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Kabuki syndrome 2 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.090
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.056
.;T;.;T;T;.
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.88
D;D;D;D;D;D
M_CAP
Pathogenic
0.94
D
MetaRNN
Benign
0.0071
T;T;T;T;T;T
MetaSVM
Uncertain
-0.21
T
MutationAssessor
Uncertain
2.3
.;.;.;.;M;.
PhyloP100
5.4
PrimateAI
Pathogenic
0.89
D
PROVEAN
Uncertain
-3.4
.;.;.;.;D;.
REVEL
Uncertain
0.35
Sift
Uncertain
0.0020
.;.;.;.;D;.
Sift4G
Uncertain
0.023
D;D;D;D;D;D
Polyphen
0.77
.;.;.;.;P;.
Vest4
0.54
MVP
0.72
MPC
1.2
ClinPred
0.060
T
GERP RS
3.8
PromoterAI
-0.018
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.80
gMVP
0.55
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6529; hg19: chrX-44732885; COSMIC: COSV65039502; COSMIC: COSV65039502; API